CD268 (BAFF Receptor) Monoclonal Antibody (eBio7H22-E16), APC, eBioscience
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0487361
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $299.65
About this award
Life Technologies Corporation was awarded contract A207_PO-0487361 by the University of Virginia on October 2, 2026, for the supply of specialized laboratory reagents. The contract is valued at $299.65 and involves the delivery of a single unit of CD268 (BAFF Receptor) Monoclonal Antibody (eBio7H22-E16) conjugated with Allophycocyanin, sourced from eBioscience. The deliverable is to be provided to Melissa A Marshall at the University of Virginia in Virginia.
This procurement represents a routine acquisition of a monoclonal antibody product commonly utilized in flow cytometry and immunological research applications. The contract fulfills the University of Virginia's requirement for this specific laboratory reagent to support ongoing research or diagnostic activities. As a purchase order-based award, this transaction reflects the standard procurement methodology employed by the contracting organization for acquiring commercially available life sciences products.
Line items
| Item | Total |
|---|---|
| CD268 (BAFF Receptor) Monoclonal Antibody (eBio7H22-E16), APC, eBioscience | $299.65 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0487361?
Contract A207_PO-0487361 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on October 2, 2026.
How much is contract A207_PO-0487361 worth?
Its cumulative value is $299.65.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award